Aardvark Therapeutics, Inc. (AARD) › Weighted Average Diluted SharesAardvark Therapeutics, Inc. (AARD): Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.19.62MYear ended 2025-12-312024-12-31: 4.00M2025-12-31: 19.62M19.62M2024-12-31 Weighted Average Diluted Shares (shares) 2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3119.62M+391.1%2026-03-23, From 2025-01-012024-12-314.00Mn/a2026-03-23, From 2024-01-01Other metrics: RevenueR&D ExpenseOperating IncomeDepreciation & AmortizationEBITDANet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShares OutstandingEPS (Basic)